Antabio's Grant - V Round

Antabio raised a round of funding on December 02, 2014. Investors include European Commission.

Antabio is a biopharmaceutical company developing novel antibacterial resistance-breakers to treat drug-resistant infections in areas of highest unmet medical need.…

Articles about Antabio's Grant - V Round: